bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: O S A J J M A M F J
2016: D N O

 
  Other news for:
Chlamydia
Physicians
Gonorrhea
Infection
Sexually Transmitted Diseases
 Resources from HONselect
Adding in Prescription for Partner Boosts STD Care
Lower chlamydia, gonorrhea rates seen when one person can obtain treatment for both partners

By Robert Preidt

TUESDAY, June 13, 2017 (HealthDay News) -- States that let doctors prescribe drugs to treat chlamydia or gonorrhea in both partners when only one makes an office visit have lower rates of the sexually transmitted diseases (STDs), a new U.S. study finds.

The approach, called expedited partner therapy (EPT), is allowed in 38 states.

University of Michigan researchers analyzed reported chlamydia cases from 2000 to 2013. In states where EPT is barred, the average increase in chlamydia infections was 17.5 cases per 100,000 people per year. This compared with 14 cases per 100,000 in states where EPT is allowed, the study found.

"We know that to most effectively treat and prevent STDs, we have to consider both the infected patient and his or her partners," lead author Dr. Okeoma Mmeje said in a university news release. She is an assistant professor of obstetrics and gynecology.

Mmeje said there are many barriers to making an office visit, from transportation and inconvenience to access to a free clinic.

"Allowing doctors to treat both patients and their partners in this way has proven to be effective at preventing reinfection and the spread of infections such as chlamydia and gonorrhea. Long term, there are many societal benefits both in health and cost," Mmeje said.

Several national agencies and organizations -- including the U.S. Centers for Disease Control and Prevention and the American Congress of Obstetricians and Gynecologists -- have endorsed expedited partner therapy. But, Mmeje said, it remains underused.

Many insurers don't cover medication costs for sexual partners, and some doctors are reluctant to treat patients without an exam due to liability concerns, according to Mmeje.

Infection rates are especially high among youth, blacks and those in southern states, the study authors noted. And most people with chlamydia and gonorrhea do not have symptoms, the investigators said.

"Our findings provide strong reasons to re-examine policies that make it difficult to access a public health measure that we know can help treat and prevent sexually transmitted diseases," Mmeje said.

The study was published online recently in the journal Sexually Transmitted Infections.

More information

The U.S. Centers for Disease Control and Prevention has more on STDs.

SOURCE: University of Michigan, news release, June 2, 2017

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=723393

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Infection
Gonorrhea
Research Personnel
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact